Regencor, Inc.; Inc.;Sanford Burnham Prebys Medical Discovery Institute;Regencor
发明人:
RUIZ-LOZANO, Pilar,MERCOLA, Mark,WEI, Ke
申请号：
EP16777438
公开号：
EP3280429A4
申请日:
2016.04.08
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
Provided herein, inter alia, are compositions and kits comprising epicardial-derived paracrine factors (such as, hypoglycosylated follistatin-like 1 (FSTL1)) for treating and repairing damage to cardiac tissue caused by cardiovascular disease, myocardial infarction (MI), other ischemic events, or cardiac-growth deficiency, as well as methods for using the same.
